CytoReason is an Israel-based biotechnology company that develops computational disease models and drug development for the treatment of cancer and inflammatory diseases.
$80M
Jul 16, 2024
-
COUR Pharmaceuticals is an Illinois-based biotechnology company that researches and develops novel immune nanoparticles for the treatment of autoimmune diseases.
$105M
Jan 29, 2024
-
CellCentric is an England-based biotechnology company that researches and develops small-molecule therapies for the treatment of patients with cancer.
$25M
Jul 10, 2023
-
Caribou is a California-based biopharmaceutical company that researches and develops gene-edited cell therapies for the treatment of cancer.
$25M
Jun 29, 2023
-
Vedanta is a Massachusetts-based biotechnology company that researches and develops oral therapies for the treatment of autoimmune and infectious diseases.
$118.5M
Feb 28, 2023
-
Frequently Asked Questions about Pfizer
What is Pfizer investing in?
Pfizer has invested in 54 companies including CytoReason, COUR Pharmaceuticals and CellCentric
What company did Pfizer invest in?
Pfizer invested in a total 54 companies including CytoReason, COUR Pharmaceuticals and CellCentric
What are the top 5 investments by Pfizer?
The top companies in which Pfizer invested are CytoReason, COUR Pharmaceuticals, CellCentric, Caribou and Vedanta
